Angiogenesis and inflammation signaling are targets of beer polyphenols on vascular cells

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1270-1279

  Negrão, Rita ^a   Costa, Raquel ^a   Duarte, Delfim ^a   Taveira Gomes, Tiago ^a   Mendanha, Mário ^a   Moura, Liane ^a   Vasques, Luísa ^a   Azevedo, Isabel ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

Author keywords

8 prenylnaringenin; angiogenesis; beer; blood vessels; endothelial cells; inflammation; isoxanthohumol; polyphenols; smooth muscle cells; xanthohumol

Indexed keywords

INTERLEUKIN 1BETA; ISOXANTHOHUMOL; MATRIGEL; PHYTOESTROGEN 8 PRENYLNARINGENIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; XANTHOHUMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BEER; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WOUND HEALING;

ANIMALS; BLOOD VESSELS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMULUS; INFLAMMATION; MICE; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PHENOLS; PROTECTIVE AGENTS; RATS; SIGNAL TRANSDUCTION;

HUMULUS; RATTUS;

EID: 78649890064     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22850     Document Type: Article

References (40)

1. Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G,. 2006. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J 20: 527-529.
2. Bertl E, Becker H, Eicher T, Herhaus C, Kapadia G, Bartsch H, Gerhauser C,. 2004. Inhibition of endothelial cell functions by novel potential cancer chemopreventive agents. Biochem Biophys Res Commun 325: 287-295.
3. Biesalski HK,. 2007. Polyphenols and inflammation: Basic interactions. Curr Opin Clin Nutr Metab Care 10: 724-728.
4. Bolca S, Li J, Nikolic D, Roche N, Blondeel P, Possemiers S, De Keukeleire D, Bracke M, Heyerick A, van Breemen RB, Depypere H,. 2010. Disposition of hop prenylflavonoids in human breast tissue. Mol Nutr Food Res 54: S284-S294.
5. Bolca S, Possemiers S, Maervoet V, Huybrechts I, Heyerick A, Vervarcke S, Depypere H, De Keukeleire D, Bracke M, De Henauw S, Verstraete W, Van de Wiele T,. 2007. Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: A dietary intervention trial with fifty healthy post-menopausal Caucasian women. Br J Nutr 98: 950-959.
6. Brunelli E, Minassi A, Appendino G, Moro L,. 2007. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 107: 140-148.
7. Carmeliet P,. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
8. Cho YC, Kim HJ, Kim YJ, Lee KY, Choi HJ, Lee IS, Kang BY,. 2008. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int Immunopharmacol 8: 567-573.
9. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E,. 2007. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246: 201-209.
10. Costa C, Incio J, Soares R,. 2007. Angiogenesis and chronic inflammation: Cause or consequence? Angiogenesis 10: 149-166.
11. Dell'Eva R, Ambrosini C, Vannini N, Piaggio G, Albini A, Ferrari N,. 2007. AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer 110: 2007-2011.
12. Folkman J,. 2007. Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286. (Pubitemid 46505878)
13. Gerhauser C,. 2005a. Beer constituents as potential cancer chemopreventive agents. Eur J Cancer 41: 1941-1954.
14. Gerhauser C,. 2005b. Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol Nutr Food Res 49: 827-831.
15. Guerreiro S, Monteiro R, Martins MJ, Calhau C, Azevedo I, Soares R,. 2007. Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells. Clin Biochem 40: 268-273.
16. Hotamisligil GS,. 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
17. Imhof BA, Aurrand-Lions M,. 2006. Angiogenesis and inflammation face off. Nat Med 12: 171-172.
18. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R,. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
19. Magalhaes PJ, Carvalho DO, Cruz JM, Guido LF, Barros AA,. 2009. Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer. Nat Prod Commun 4: 591-610.
20. Malinda KM, Sidhu GS, Banaudha KK, Gaddipati JP, Maheshwari RK, Goldstein AL, Kleinman HK,. 1998. Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol 160: 1001-1006.
21. Milligan S, Kalita J, Pocock V, Heyerick A, De Cooman L, Rong H, De Keukeleire D,. 2002. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123: 235-242.
22. Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A, Ferrari N,. 2008. Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Mol Cancer Ther 7: 2692-2702.
23. Monteiro R,. 2009. Chronic inflammation in the metabolic syndrome. In:, Soares R, Costa C, editors. Oxidative stress, inflammation and angiogenesis in the metabolic syndrome. United Kingdom: Springer Science, Hardcover. pp 65-84.
24. Monteiro R, Calhau C, Silva AO, Pinheiro-Silva S, Guerreiro S, Gartner F, Azevedo I, Soares R,. 2008. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. J Cell Biochem 104: 1699-1707.
25. Negrão RIJ, Lopes R, Azevedo I, Soares R,. 2007. Evidence for the effects of xanthohumol in disrupting angiogenic vessels, but not stable ones. Int J Biomed Sci 3: 279-286.
26. Niethammer P, Grabher C, Look AT, Mitchison TJ,. 2009. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459: 996-999.
27. Nikolic D, Li Y, Chadwick LR, Pauli GF, van Breemen RB,. 2005. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J Mass Spectrom 40: 289-299.
28. Nikolic D, Li Y, Chadwick LR, van Breemen RB,. 2006. In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops (Humulus lupulus L.). Pharm Res 23: 864-872.
29. Oak MH, El Bedoui J, Schini-Kerth VB,. 2005. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16: 1-8.
30. Pepper MS, Hazel SJ, Humpel M, Schleuning WD,. 2004. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. J Cell Physiol 199: 98-107.
31. Possemiers S, Rabot S, Espin JC, Bruneau A, Philippe C, Gonzalez-Sarrias A, Heyerick A, Tomas-Barberan FA, De Keukeleire D, Verstraete W,. 2008. Eubacterium limosum activates isoxanthohumol from hops (Humulus lupulus L.) into the potent phytoestrogen 8-prenylnaringenin in vitro and in rat intestine. J Nutr 138: 1310-1316.
32. Rad M, Humpel M, Schaefer O, Schoemaker RC, Schleuning WD, Cohen AF, Burggraaf J,. 2006. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol 62: 288-296.
33. Rocha A, Azevedo I, Soares R,. 2007. Anti-angiogenic effects of imatinib target smooth muscle cells but not endothelial cells. Angiogenesis 10: 279-286.
34. Soares R,. 2009. Angiogenesis in the metabolic syndrome. In:, Soares R, Costa C, editors. Oxidative stress, inflammation and angiogenesis in the metabolic syndrome. United Kingdom: Springer Science, Hardcover. pp 85-99.
35. Soares R, Azevedo I,. 2007. Inhibition of S1P by polyphenols prevents inflammation and angiogenesis: NFkappaB, a downstream effector? Free Radic Biol Med 42: 311.
36. Soares R, Balogh G, Guo S, Gartner F, Russo J, Schmitt F,. 2004. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol 18: 2333-2343.
37. Soares R, Guo S, Gartner F, Schmitt FC, Russo J,. 2003. 17 beta-estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis 6: 271-281.
38. Stevens JF, Page JE,. 2004. Xanthohumol and related prenylflavonoids from hops and beer: To your good health. Phytochemistry 65: 1317-1330.
39. Stevenson DE, Hurst RD,. 2007. Polyphenolic phytochemicals-Just antioxidants or much more? Cell Mol Life Sci 64: 2900-2916.
40. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS,. 2003. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102: 161-168.